Second primary malignancies after autologous hematopoietic cell transplantation for multiple myeloma

Recent studies demonstrate an increased risk of second primary malignancies (SPM) in multiple myeloma (MM) patients on maintenance lenalidomide following autologous stem cell transplantation (ASCT). There may be other risk factors driving SPM post-ASCT in MM, so we explored this possibility through...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Krishnan, Amrita Y., Mei, Matthew, Sun, Can-Lan, Thomas, Sandra H., Berano Teh, Jennifer, Kang, Tongjun, Htut, Myo, Somlo, George, Sahebi, Firoozeh, Forman, Stephen J., Bhatia, Smita
Format: Artigo
Jezik:Inglês
Izdano: 2012
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3553262/
https://ncbi.nlm.nih.gov/pubmed/23073267
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2012.09.023
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki